UNSPSC 51284107: Cefmenoxime

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KBZ4844CXN. European Medicines Agency schedules Cefmenoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07397MIG. Cefmenoxime generally arises in the molecular formula C16H17N9O5S3.

UNSPSC 51284107 Cefmenoxime, a Commodity code, shows no recent state and local procurement activity for the pharmaceutical product itself; the code's nominal scope does not align with the available opportunities posted under this classification. Recent solicitations tagged to this code actually pursue naloxone, medical and first aid supplies, generic multi-source pharmaceuticals, and over-the-counter products through various procurement mechanisms — none of which are cefmenoxime-specific procurements. State and local health departments, fire-rescue divisions, and cooperative purchasing alliances are the primary issuing bodies active in pharmaceutical and medical-supply procurement, but the available records do not show demand specifically for cefmenoxime as an individual line item.

The geographic spread of pharmaceutical and medical-supply activity in the source spans Florida (Seminole County IFB for naloxone and drug deactivation systems, due July 26, 2023), Texas (Texas HHS Commission RFI for direct-to-manufacturer prescriptions, due April 3, 2026), Florida (City of Tampa IFB for medical and first aid supplies, due March 13, 2026, with an estimated contract value of $700,000.00), and Minnesota and Oregon through MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The source does not support pursuit of cefmenoxime specifically under this code based on recent activity.